Company news
Mayinglong Pharmaceutical Group Co., Ltd. news in 2024
Mayinglong Pharmaceutical Group Co., Ltd.'s news releases, calls and decks from 2024, newest first.
Announcement on Obtaining Notice of Approval for Drug Clinical Trial
December 6, 2024
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2024
December 2, 2024
Announcement on Release of Pledge and Re-pledge of Some Shares Held by Controlling Shareholders
November 18, 2024
Announcement on Resolution of the 17th Meeting of the 11th Board of Directors
November 15, 2024
Report for Q3 2024
October 25, 2024
Semi-annual Report in 2024
August 23, 2024
Announcement on Extending the Duration of Industrial Investment Fund
August 20, 2024
Announcement on Implementation of Dividend Distribution for 2023
July 19, 2024
Announcement on Resolutions of 2023 Annual General Meeting
June 18, 2024
Announcement on Convening Performance Meeting for 2023 and 1st Quarter of 2024
June 11, 2024
Announcement on Changing Name of Shareholder
June 4, 2024
Notice on Convening 2023 Annual General Meeting
May 28, 2024
Announcement on Attending Online Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction in 2024
May 10, 2024
Announcement on Resolutions of 12th Session of 11th Board of Directors
April 12, 2024